Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic

Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic

Zydus Lifesciences (previously Cadila Healthcare), through its US subsidiary Zydus Pharmaceuticals (USA), has secured tentative approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial from the US Food and Drug Administration (FDA). The approved product is a generic version of Levothyroxine Sodium injection manufactured by Fresenius Kabi USA. Levothyroxine Sodium injection […]